Answer
Nov 28, 2024 - 10:29 AM
Bictegravir, emtricitabine, and tenofovir alafenamide are combined in a single tablet used for the treatment of HIV-1 infection. This combination is designed to suppress the virus in adults and pediatric patients who weigh at least 25 kg, helping to achieve and maintain an undetectable viral load. It is part of antiretroviral therapy aimed at improving immune function and reducing the risk of HIV-related complications.
